Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Quantifying Ocular Surface Aberrations After Tear Film Interventions

NCT: NCT06966349 · COMPLETED

NCT IDNCT06966349
StatusCOMPLETED
Start Date2025-06-10
Completion2026-01-29

Brief Summary

The CA-800 Corneal Analyzer (Visia Imaging S.R.L., Italy) is a device that can measure small imperfections in the tear film when the eyes are open. The goal of this study is to see if the device can detect changes in the tear film after instillation of an eye drop or when contact lenses are worn.

Frequently Asked Questions

What is Quantifying Ocular Surface Aberrations After Tear Film Interventions?

Quantifying Ocular Surface Aberrations After Tear Film Interventions is a clinical trial registered under NCT06966349. Current status: COMPLETED.

What is the status of NCT06966349?

The current status of NCT06966349 (Quantifying Ocular Surface Aberrations After Tear Film Interventions) is: COMPLETED.

When did Quantifying Ocular Surface Aberrations After Tear Film Interventions start?

Quantifying Ocular Surface Aberrations After Tear Film Interventions started on 2025-06-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.